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Background: New technologies could facilitate changes in lifestyle and improve public health. However, no large
randomized, controlled studies providing scientific evidence of the benefits of their use have been made. The aims
of this study are to develop and validate a smartphone application, and to evaluate the effect of adding this tool
to a standardized intervention designed to improve adherence to the Mediterranean diet and to physical activity.
An evaluation is also made of the effect of modifying habits upon vascular structure and function, and therefore
on arterial aging.
Methods/Design: A randomized, double-blind, multicenter, parallel group clinical trial will be carried out. A total of
1215 subjects under 70 years of age from the EVIDENT trial will be included. Counseling common to both groups
(control and intervention) will be provided on adaptation to the Mediterranean diet and on physical activity. The
intervention group moreover will receive training on the use of a smartphone application designed to promote a
healthy diet and increased physical activity, and will use the application for three months. The main study endpoints will
be the changes in physical activity, assessed by accelerometer and the 7-day Physical Activity Recall (PAR) interview, and
adaptation to the Mediterranean diet, as evaluated by an adherence questionnaire and a food frequency questionnaire
(FFQ). Evaluation also will be made of vascular structure and function based on central arterial pressure, the
radial augmentation index, pulse velocity, the cardio-ankle vascular index, and carotid intima-media thickness.
Discussion: Confirmation that the new technologies are useful for promoting healthier lifestyles and that their
effects are beneficial in terms of arterial aging will have important clinical implications, and may contribute to
generalize their application in favor of improved population health.
Trial registration: Clinical Trials.gov Identifier: NCT02016014
Keywords: Physical activity, Food, Information and communication technologies, Arterial agingBackground
Benefits of physical activity
There is abundant scientific evidence of the biological
and psychological benefits of physical activity [1]. On
the other hand, low cardiopulmonary fitness is associ-
ated with an increased risk of cardiovascular morbidity-
mortality, while improved physical fitness is associated* Correspondence: Lgarciao@usal.es
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article, unless otherwise stated.with a decrease in mortality risk [2]. The results of a
metaanalysis on the influence of physical activity upon
blood pressure indicate a mean reduction of 3.8 mmHg
in systolic blood pressure (SBP) and 2.6 mmHg in dia-
stolic blood pressure (DBP) [3]. Aerobic exercise could
attenuate arterial hardening as observed in the Baltimore
Longitudinal Study, in which male athletes had a lesser
pulse wave velocity (PWV), augmentation index (AIx)
and SBP than sedentary individuals [4]. Improvement in
carotid artery elasticity has also been recorded in previ-
ously sedentary subjects who started a physical exercised Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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crease in atherosclerosis progression in humans [6]. The
results of the first phase of the EVIDENT study [7] have
demonstrated an association between physical exercise
and improved vascular structure and function [8]. An
association has also been reported between the time
people spend seated and mortality. However, the results
are even more relevant on combining the time spent
seated (6 hours a day) with low physical activity (< 24.5
METS/hours/week), yielding a relative risk (RR) of 1.94
(95% confidence interval (95% CI): 1.70-2.20) for women
and 1.48 (95% CI: 1.33-1.65) for males, as opposed to
those who spend less time seated and have greater activ-
ity [9]. The EVIDENT study has also found increased
arterial stiffness to be related to the number of hours
spent watching television [10]. On the other hand,
physical activity shows an inverse correlation to the con-
centrations of fibrinogen [11].Interventions for increasing physical activity
Although there is abundant evidence of the benefits of
physical activity, the percentage of individuals who
may be considered active is low in our setting [12]. In
the United Kingdom, the prevalence of sedentarism
reaches 60% in males and 74% in females [13], while in
Spain the PEPAF (Experimental Program for Physical
Activity Promotion) recorded a 75% sedentarism rate
[14]. Different methods have been used in an attempt
to promote physical activity, though with conflicting
results. A Cochrane review concluded that there are no
data to support the hypothesis that multiple-component
community-based procedures are effective in increasing the
physical activity of the population [15]. A recent metaanaly-
sis of studies in the primary care setting has concluded that
the promotion of physical activity in sedentary subjects
increases the number of individuals who are classified as
active subjects after 12 months (odds ratio (OR): 1.42;
95% CI: 1.17-1.73), though the effect has not been demon-
strated over the long term [16,17]. The PEPAF study inter-
vention resulted in an increase in physical activity versus
the controls of 18 min./week (95% CI: 6–31 min./week),
with a rise in METS/hours/week of 1.3 [95% CI: 0.4-2.2].
The proportion of individuals reaching the recommended
minimum physical activity was 3.9% greater in the interven-
tion group (1.2% to 6.9%) than in the control series. Few
randomized, controlled clinical trials have evaluated the im-
pact of interventions in terms of a decrease in sitting time,
though an intervention designed to promote walking while
working was able to reduce the daily sitting time by
21 minutes [18]. Evidence is even more limited in pop-
ulations with chronic diseases, though an intervention
in type 2 diabetics has recorded a reduction in daily sit-
ting time of 23 minutes [19].Benefits of the Mediterranean diet
The Mediterranean diet is presently regarded as the
model of most healthy diet. It reflects the traditional
eating habits of countries such as Greece, southern Italy
and Spain. The main characteristics of this diet are:
a) important consumption of cereals, legumes, nuts, fruit
and vegetables; b) use of olive oil for cooking purposes
and for the dressing of salads and vegetables (represent-
ing the main source of fat in the form of monounsatu-
rated fatty acids); c) moderate to high consumption of
fish; d) moderate to low consumption of chicken and
dairy products; e) low consumption of red meats and
meat products; and f) moderate alcohol consumption,
mainly in the form of red wine with meals [20]. There is
convincing evidence that the Mediterranean diet may
have a positive effect upon endothelial function [21] and
can lower peripheral blood pressure [22]. A correlation
has also been established with vascular structure, as
assessed by carotid intima-media thickness [23], as well
as with decreased mortality due to any cause [24] and,
more specifically, due to coronary disease [25]. The results
of the EVIDENT I study found obese males to show the
poorest adherence [26].
Interventions for improving eating habits
(Mediterranean diet)
Few intervention studies with the Mediterranean diet
have been carried out. A randomized clinical trial (the
Lyon Diet Heart Study) [27], involving a modified model
of the Mediterranean diet versus a control diet, con-
cluded that the Mediterranean diet is associated with a
marked reduction in cardiovascular mortality and in the
incidence of cardiovascular complications among pa-
tients who have suffered myocardial infarction. However,
prior to publication of the PREDIMED (Prevention with
Mediterranean Diet) study [22], no randomized clinical trial
had investigated whether the effects of the Mediterranean
diet are superior to those of a low-fat diet in relation to the
primary prevention of cardiovascular diseases. The PRE-
DIMED study [22] was designed to determine whether the
Mediterranean diet supplemented with virgin olive oil or
nuts prevents the development of major cardiovascular
complications in high vascular risk individuals, compared
with a low-fat diet. In its initial phase, this study recorded
an average increase of 1.8 points on the 14-point scale
assessing adherence to the Mediterranean diet, versus an
increase of 0.3 points in the control group [28]. During the
first year, this implied a decrease in the prevalence of
metabolic syndrome and its components and in the in-
cidence of diabetes mellitus [28,29]. Furthermore, after
four years of follow-up, the subjects in the intervention
groups (Mediterranean diet) showed a 30% decrease in
the incidence of major cardiovascular complications
versus the control series [30].
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Aging is associated with increased arterial stiffness, which
can be evaluated with different clinical and biological
tools. The accepted gold standard for assessing arterial
stiffness is the carotid-femoral pulse wave velocity (PWV)
[31], which has been correlated to increased morbidity-
mortality in both patients with cardiovascular disease and
in healthy individuals [32]. Central arterial pressure has
also been shown to be more strongly correlated to cardio-
vascular morbidity and mortality than peripheral blood
pressure [33]. The central and peripheral augmentation
indexes are markers of arterial stiffness which together
with aortic systolic pressure and aortic pulse pressure
complement the information afforded by pulse wave
velocity. The cardio-ankle vascular index (CAVI) also eval-
uates arterial stiffness, and is able to estimate the risk of
atherosclerosis and vascular age. This parameter moreover
is independent of arterial pressure [34,35].
Information technology as a support for improving health
Considering the trend in recent years in the use of mo-
bile telephones, and the recent introduction of smart-
phones, it can be estimated that within 10 years, a full
80-90% of the population in developed countries will
have one of these devices [36], and probably with many
more applications than are available today. Information
technology is finding many applications in the field of
health and Medicine. Recently, short message service
(SMS) communication has demonstrated its usefulness
in helping people to stop smoking [37]. Smartphone ap-
plications designed to assist healthcare personnel both
in training and in decision making processes in daily
clinical practice and in emergency care are increasing,
and there is already some evidence of their usefulness
[38]. Such applications have also been used in patient
care for monitoring biological parameters [39], detecting
falls in the elderly [40], preventing cognitive impairment
[41] and monitoring diabetes [42], as well as in cardiac
rehabilitation [43] and also in the promotion of physical
activity [44] and the management of [45]. Communica-
tion based on the use of mobile phones, and especially
smartphones, has a strong potential to transform health-
care and clinical interventions in the community [36].
However, its effectiveness needs to be evaluated in mul-
ticenter clinical trials, as recommended by the United
States Food and Drug Administration (FDA), in a way
similarly to what is done with drug substances. A metaa-
nalysis of the use of information technology in dietetic
evaluation has concluded that it could improve dietary
assessment in some population groups, though improved
validity and reliability is required in evaluating micronu-
trients [46]. Many applications have been developed in
the field of health, and specifically in relation to diet and
exercise, destined for use by the general population.Although the acceptance and ease of use of such appli-
cations has been evaluated among young adults for the
registry of eating habits and physical activity [47], they
have not been tested in other population types, and little
is known of their effectiveness in relation to health out-
comes. Few studies have validated these tools, though
some investigations are presently in course [48]. Even
less work has been done to explore the impact of such
applications in relation to increased physical activity and
improved eating habits, and hence in terms of improve-
ment of the health of the people who use them [49].
The present study aims to provide evidence of the effect
which the new information and communication technolo-
gies, and specifically smartphone applications, could have
as tools supporting changes in favor of more healthy life-
styles. An evaluation is also made of the effect of such
changes upon arterial aging.
Objectives
The first objective of this study is to develop and valid-
ate a smartphone application supporting standardized
counseling to increase physical activity and adapt eating
habits to the recommendations of the Mediterranean
diet. The second and central objective of the study is to
quantify the effect attributable to the developed smart-
phone application in terms of the modification of habits,
adherence to the Mediterranean diet, and increased
physical activity. Lastly, an evaluation is made of the ef-
fect of the modification of habits upon vascular structure
and function, and therefore on arterial aging.
Methods/Design
Design and setting
This is a randomized, multicenter, double-blind clinical
trial involving two parallel groups, designed to evaluate
the possible effects of adding an information and com-
munication tool (intervention) in support of behavioral
and educational counseling (control) to promote increased
physical activity and adaptation of eating habits to the
Mediterranean diet.
The study will include 6 groups of the Research Network
on Preventive Activities and Health Promotion (REDIAPP)
in Bilbao, Cuenca, Zaragoza, Valladolid, Barcelona and
Salamanca (Spain), as a continuation of the EVIDENT
project developed in 2010–2012.
Subjects
Study population
The study population will be selected from the EVIDENT
project [7], comprising 1,553 subjects randomly selected in
the primary care setting. The study will exclude patients
over 70 years of age (due to difficulties in using information
and communication tools among such individuals), those
unable to do exercise or follow the Mediterranean diet, as
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criteria of the EVIDENT project (known coronary or
cerebrovascular atherosclerotic disease; heart failure;
moderate or severe chronic obstructive pulmonary
disease; musculoskeletal disease that limited walking;
advanced respiratory, renal, or hepatic disease; severe
mental disease; treated oncological disease diagnosed
in the 5 years) [7]. The rest of the subjects will be ran-
domised on a centralized basis from Salamanca using
the Epidat 4.0 software package to intervention (IG)
and control groups (CG) with a ratio of 1/1. Of the
1553 subjects, it is estimated that 10-15% will be ex-
cluded; the resulting sample therefore will comprise
1,350 individuals. We estimate that another 10% will
reject participation, i.e., we expect to include at least
1,215 subjects in the final sample.Sample size
Estimation of sample size has been made for the main
study endpoints. Regarding physical exercise, and as-
suming α = 0.05 and β = 0.10, with a standard deviation
(SD) of 154, we would need 1,110 subjects (555 per
group) to detect an increase of 30 counts/minute in IG
versus CG. In turn, regarding the Mediterranean diet
(MD), and assuming α = 0.05 and β = 0.10, with a stand-
ard deviation (SD) of 2, we would need 676 subjects
(338 per group) to detect an increase of 0.5 points in the
MD questionnaire in IG versus CG. The inclusion of
1,215 subjects is considered sufficient to detect clinically
relevant differences in the main study endpoints, assum-
ing the cluster effect of the design.Figure 1 Smartphone application (APP) EVIDENT II, main screen and pVariables and measurement instruments
The general and potentially effect-modifying variables, such
as age, gender, occupation, smoking, alcohol consumption,
personal history and drug use will be documented.
Mobile phone tool for evaluating healthy lifestyles
The developed tool is the result of an agreement be-
tween the company CGB and the GIAPCyL research
group of the REDIAPP (RD12/0005/0004), through the
Infosalud Fundation (Figures 1 and 2). The tool is a
smartphone application with a user-friendly environ-
ment that is easy for adults to handle. It can be used to
quickly evaluate the adaptation of living habits to healthy
lifestyle recommendations referred to both eating and phys-
ical activity. An evaluation will be made of the quantity and
quality of food intake according to standardized references,
with the purpose of assessing adaptation of the eating
habits of the individual to the Mediterranean diet. Based
on adequate proportions of primary food elements, a per-
sonalized recommendation will be produced, depending
on the entered intake characteristics. The application will
generate detailed information on the eating deviations
(diet composition and calories), with a view to facilitating
changes in habits. Physical activity also will be evaluated,
using an accelerometer included in the smartphone appli-
cation, and which will count the steps taken over a period
of 24 hours. The activity reported by the subject during
periods in which the device is not used (e.g., swimming
and other sports) also will be considered, assessing com-
pliance with the exercise objectives and providing recom-
mendations to increase activity and reach the target of
10,000 steps a day defining an active individual. A balancehysical activity.
Figure 2 Smartphone application (APP) EVIDENT II, nutrition screens.
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the day, and specific recommendations will be produced
for the next day/days. The information will be stored in
the device and will be downloaded on occasion of the con-
trol visits for subsequent analysis.
Physical activity
Physical activity will be measured by an accelerometer
and by the 7-day physical activity recall (PAR). Acti-
Graph GT3X accelerometers (ActiGraph, Shalimar, FL,
USA) will be used to evaluate principal endpoint of
psychical activity, which have been previously validated
[50-52]. ActiGraph is a monitor that uses a piezoelectric
acceleration sensor to filter and convert the signals pro-
duced from the sensor in samples collected at a preset
frequency in hertz. The samples are summed over a
user-specified time sampling interval, called an “epoch”.
Output from the ActiGraph is in the form of activity
“counts,” where one count is equivalent to 16 milli-g per
second, and where g is equal to 9.825 m · s − 2, the accel-
eration of gravity. Activity “counts” are recorded to the
internal memory of accelerometers by converting accel-
eration units over a given epoch [53]. Subjects will wear
the accelerometer fastened with an elastic strap to the right
side of the waist for seven consecutive days with habitual
physical activity, except for bathing and performing activ-
ities in the water. All subjects will be verbally instructed on
how to use the accelerometer. The accelerometer will
be set to record physical activity data every minute. The
MAHUFFE software, available from: http://www.mrc-epid.
cam.ac.uk/research/resources/materials-transfer-disclaimer/
physical-activity-downloads/ (accessed: 30/12/2013), will beused to analyze the data. Sequences of 10 or more consecu-
tive zero counts will be considered non-wearing time and
excluded from the analyses. Inclusion criteria will be a
minimum of 4 days of recording, including at least 1 week-
end day and at least 600 registered minutes per day. The
main outcome variable from the activity monitor will be
the average intensity of physical activity (counts/minute),
calculated with equal weighting given to each day (regard-
less of registered time per day). The intensity of physical
activity will be determined according to the cut-off points
proposed by Freedson [54], sedentary (<100 counts/mi-
nute), light (100–1952 counts/minute), moderate (1952–
5724 counts/minute) vigorous (>5724 counts/minute) and
very vigorous (>9498 counts/minute). Moderate-vigorous
activity will be considered as activity accumulated from all
bouts lasting at least 1 min.
The 7-day PAR is a general measure of physical activ-
ity, which has been recognized as valid and reliable tool
in recent years and is widely used in epidemiological,
clinical and behavior change studies. It consists of a
semi-structured interview (10-15 minutes) in which par-
ticipants provide an estimate of the number of hours
dedicated to physical or occupational activities requiring
at least a moderate effort in the past seven days. The
categories collected are moderate, vigorous, and very
vigorous physical activity. The amount of time dedicated
to each activity is multiplied by the mean metabolic
equivalents (METs) of each category: light activity 1.5,
moderate 4, vigorous 6, and very vigorous 10. The sum
of the products of the hours dedicated to each activity
and its estimated mean energy expenditure (MET) pro-
vides an estimation of the kilocalories per kilogram used
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will be estimated in METs/hour/week and active persons
were considered as those doing at least 30 minutes of mod-
erate activity, five days a week, or at least 20 minutes of vig-
orous activity, 3 days a week or 450 MET ·min · wk−1 [12].
Persons not reaching this level of physical activity were
considered sedentary.
Questionnaire hours seated (Marshall): Evaluates the
hours that the individual is sitting, in their work, in the
displacements and at home, during the week and the
weekend [55].
Nutrition
Adherence to the Mediterranean diet, principal endpoint
of alimentation, will be measured using the validated 14-
point Mediterranean Diet Adherence Screener (MEDAS)
[56], developed by the PREDIMED study group. The
MEDAS is a valid instrument for rapid estimation of
adherence to the Mediterranean diet and may be useful
in clinical practice. The 14-item screener includes 12
questions on food consumption frequency and two ques-
tions on food intake habits considered characteristic of
the Spanish Mediterranean diet. Each question will be
scored as 0 or 1. One point will be give for using olive
oil as the principal source of fat for cooking, preferring
white meat over red meat, or for consuming: 1) 4 or
more tablespoons (1 tablespoon = 13.5 g) of olive oil/d; 2) 2
or more servings of vegetables/d; 3) 3 or more pieces of
fruit/d; 4) < 1 serving of red meat or sausages/d; 5) < 1
serving of animal fat/d; 6) < 1 cup (1 cup = 100 ml) of
sugar-sweetened beverages/d; 7) 7 or more servings of red
wine/wk; 8) 3 or more servings of pulses/wk; 9) 3 or more
servings of fish/wk; 10) fewer than 2 commercial pastries/
wk; 11) 3 or more servings of nuts/wk; or 12) 2 or more
servings/wk of a dish with a traditional sauce of toma-
toes, garlic and onion. The end score will range from 0
to 14. Adequate adherence to the Mediterranean diet
will be assumed when the total score is above or equal
to 9 points [56].
The dietary habits of participants and information about
dairy products were assessed using a semi-quantitative 137-
item food-frequency questionnaire previously validated in
Spain [57]. The questionnaire was based on the typical
portion sizes that were multiplied by the consumption
frequency for each food. This estimated frequency corre-
sponds to the previous year at the time of the interview and
it is divided into 9 intake frequencies ranging from never to
more than 6 servings/day. This will be used to estimate
daily energy intake, essential nutrients, vitamins, fiber, anti-
oxidants and other nutrients.
Laboratory determinations
Venous blood sampling will be performed between 08:00
and 09:00 hours after the individuals fasted and abstainedfrom smoking and the consumption of alcohol and caffein-
ated beverages for the previous 12 hours. Fasting plasma
glucose, creatinine, uric acid, serum total cholesterol, HDL-
cholesterol and triglyceride concentrations will be mea-
sured using standard enzymatic automated methods.
LDL cholesterol will be estimated by the Friedewald
equation when the direct parameter will be not avail-
able. Glycated haemoglobin will be measured with an
immune-turbidimetric assay. High sensitive C-reactive
protein levels and fibrinogen concentrations will be
determined by immunoturbidimetric assay. Blood sam-
ples will be collected in the respective health centers,
and all will be analyzed at the hospital of the city par-
ticipating in external quality assurance programs of the
Spanish Society of Clinical Chemistry and Molecular
Pathology.
Anthropometric measurements
Body weight will be determined on two occasions using
a homologated electronic scale (Seca 770; Medical scale
and measurement systems, Birmingham, United Kingdom)
following due calibration (precision ± 0.1 kg), with the pa-
tient wearing light clothing and shoeless. These readings
will be rounded to 100 g. Height in turn will be measured
with a portable system (Seca 222; Medical scale and
measurement systems, Birmingham, United Kingdom),
recording the average of two readings, and with the pa-
tient shoeless in the standing position. The values will be
rounded to the closest centimeter. Body mass index
(BMI) will be calculated as weight (kg) divided by height
squared (m2). A value of > 30 kg/m2 will be taken to de-
fine obesity. Waist circumference will be measured using
a flexible graduated measuring tape with the patient in
the standing position without clothing. The upper border
of the iliac crests will be located, and the tape will be
wrapped around above this point, parallel to the floor, en-
suring that it will be adjusted without compressing the
skin. Adiposity indices, waist-height and waist-hip, will
also be calculated.
Office or clinical blood pressure
Office blood pressure measurement will involve three
measurements of systolic blood pressure (SBP) and dia-
stolic blood pressure (DBP), using the average of the last
two, with a validated OMRON model M10-IT sphygmo-
manometer (Omron Health Care, Kyoto, Japan), by fol-
lowing the recommendations of the European Society of
Hypertension [58]. Pulse pressure will be estimated with
the mean values of the second and third measurements.
Central blood pressure and radial augmentation index
Central blood pressure (CBP) and radial augmentation
index (rAIx) will be measured with Pulse Wave Application
Software (B-pro (A-Pulse)) (Health STATS International)
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tion to estimate central blood pressure (CASP). This device
has been validated in asian hypertensives and healthy cau-
casians [59,60]. rAIx is a measurement taken directly from
the late systolic shoulder of the peripheral arterial wave-
form, and is defined as the ratio of the difference between
the 2nd peak and diastolic pressure to the difference
between the 1st peak and diastolic pressure [61], it is age-
dependent and could be a useful index of vascular aging
[62]. rAIx will be calculated as follows: (Second peak sys-
tolic blood pressure [SBP2] - diastolic blood pressure
[DBP])/(first peak SBP - DBP) × 100 (%) and it will be ad-
justed for heart rate at 75 bpm and it will be reported as
rAIx75. Specific aspects regarding the validity and reliability
of the measurement of central blood pressure and augmen-
tation index have been reported elsewhere [60]. In brief,
the intra-observer reliability was evaluated in 20 subjects
by using the intraclass correlation coefficient (ICC), that
showed values of r = 0.971 (95% CI: 0.923 to 0.989) for
CASP and 0.952 (95% CI: 0.871 to 0.982) for rAIx. Accord-
ing to the Bland-Altman analysis, the mean difference
for intraobserver agreement (95% limits of agreement)
were −0.056 (−9.41 to 9.30) for CASP and 2.50 (−14.43
and 19.46) for rAIx. In 104 subjects we examined the
agreement of measurements with SphygmoCor and
found an ICC for CASP r = 0.972 (95%CI 0.959 to 0.981)
and for rAIx r = 0.599 (95% CI: 0.409 to 0.728). In
Bland–Altman analysis the mean difference for intraob-
server agreement (95% limits of agreement) were 1.47
(0.47 to 2.47) in CASP and 5.85 (1.75 to 9.96) in rAIx.
Assessment of vascular structure by carotid intima media
thickness (IMT)
Carotid ultrasound to assess C-IMT will be performed by
two investigators trained for this purpose before starting
the study. A Sonosite Micromax ultrasound device paired
with a 5–10 MHz multi-frequency high-resolution linear
transducer with Sonocal software will be used for perform-
ing automatic measurements of carotid IMT in order to
optimize reproducibility. Measurements will be made of
the common carotid after the examination of a 10 mm lon-
gitudinal section at a distance of 1 cm from the bifurcation,
performing measurements in the proximal and in the distal
wall in the lateral, anterior and posterior projections, fol-
lowing an axis perpendicular to the artery to discriminate
two lines, one for the intima-blood interface and the other
for the media-adventitious interface. A total of 6 measure-
ments will be obtained of the right carotid and other 6 of
the left carotid, using average values (average carotid IMT)
and maximum values (maximum carotid IMT) automatic-
ally calculated by the software [63]. The measurements will
be obtained with the subject lying down, with the head ex-
tended and slightly turned opposite to the examined carotid
artery. The reliability was evaluated before the study beganusing the intraclass correlation coefficient, which showed
values of 0.974 (95% CI: 0.935 to 0.990) for intra-observer
agreement on repeated measurements in 20 subjects, and
0.897 (95% CI:0.740 to 0.959) for inter-observer agreement.
According to the Bland-Altman analysis, the mean differ-
ence for intraobserver agreement (95% limits of agreement)
was 0.022 (95% CI: −0.053 to 0.098) and intra-observer
agreement was 0.012 (95% CI: −0.034 to 0.059). The aver-
age IMT will be considered abnormal if it measured
> 0.90 mm, or if there will be atherosclerotic plaques with a
diameter of 1.5 mm or a focal increase of 0.5 mm or 50% of
the adjacent IMT [64].
Cardio-ankle vascular index and ankle-brachial index
Cardio-Ankle Vascular Index (CAVI) and Ankle-brachial
index (ABI) will be measured using Vasera device VS-
1500® (Fukuda Denshi). For the study, the lowest ankle-
brachial index obtained will be considered. The pulse
wave velocity (PWV) will be calculated, as well as
Cardio-Ankle Vascular Index (CAVI), which gives a
more accurate calculation of the atherosclerosis degree.
CAVI integrates cardiovascular elasticity derived from the
aorta to the ankle pulse velocity through an oscillometric
method and it is used as a good measure of vascular stiff-
ness and it doesn’t depend on blood pressure [35]. CAVI
values will be automatically calculated by substituting the
stiffness parameter β in the following equation to detect the
vascular elasticity and the cardio-ankle PWV: Stiffness
parameter β = 2ρ x 1/(Ps –Pd) x ln (Ps/Pd) x PWV2, where
ρ is the blood density, Ps and Pd are SBP and DBP in
mmHg, and the PWV is measured between the aortic valve
and ankle. The average coefficient of the variation of the
CAVI is less than 5%, which is small enough for clinical use
and confirm that CAVI has favorable reproducibility [34].
Cardio-Ankle Vascular Index and Ankle-brachial index will
be measured at rest.
Analysis of motivation to change
The model of Prochaska and Diclemente will be used
[65]. The motivation stage will be classified on occasion
of each interview, based on the following criteria: a) Pre-
contemplation: The subjects are unaware that certain
behaviors place their health at risk or that they have a
health problem; alternatively, they are aware of the exist-
ence of a health problem but are reluctant to accept
changes in behavior. b) Contemplation: The subjects are
aware that certain behaviors place their health at risk or
that they have a health problem, and agree to introduce
changes within 6 months. c) Determination: The sub-
jects seriously intend to change their behaviour in the
near future (within 30 days). d) Action: The subjects are
actively working upon changes in behavior that affect
health or the identified health problem. e) Maintenance:
The subjects routinely adopt the acquired behaviors.
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the new behavior persists for over 6 months. f ) Relapse:
The subjects start the cycle over again, i.e., they no lon-
ger adhere to the desired behavior.Adherence to the tool
Adherence will be assessed by means of the Morisky-
Green test [66], and by assessing the number and days of
recordings in the device.Intervention
Common to both groups
Counseling on physical activity Both groups (control
and intervention) will receive counseling on physical
activity with a view to favoring compliance with the
current recommendations on physical activity in the
general population. The intervention has demonstrated
its effectiveness in the PEPAF study [14] and in the
Prescribe Vida Saludable (PSV) program (Osakidetza).
Counseling will consist of an individual visit lasting 15 mi-
nutes in which an explanation will be given of the health
benefits of physical activity, with the recommendation to
perform at least 30 minutes of moderate activity 5 days a
week, or 20 minutes of vigorous activity three days a week.
Counseling will be standardized in both groups, and the
subjects will receive an informational brochure (Additional
file 1) on the session. The first part (5 min.) will address
the recommendations on physical exercise in relation
to cardiovascular health. The second part (8 min.) will
develop knowledge of the intensity of some specific
physical activities such as walking, riding a bicycle, or
other activities. The last part (2 min.) will be dedicated
to answering questions and doubts. Specific advice will
be given to reduce the number of hours spent sitting.Nutritional counseling Both groups (control and inter-
vention) will receive nutrition counseling aimed at favor-
ing adherence to the MD. This intervention has been
shown to be effective in the PREDIMED study [22].
Counseling will consist of an individual visit lasting
15 minutes in which the concepts of the MD will be ex-
plained, with insistence upon the importance of comply-
ing with each of the recommended points. Counseling
will be standardized in both groups, and the subjects will
receive an informational brochure (Additional file 1) on
the session. The first part (3 min.) will develop the
concept of the MD. The second part of the session
(10 min.) will focus on each particular recommendation,
with brief and clear messages. The last part of the inter-
view (2 min.) will be dedicated to answering questions
and doubts.Specific of the intervention group
The subjects in the IG will receive a smartphone for
three months, corresponding to the intervention period.
A first visit lasting 15 minutes will be used to provide
training in the use of the device, which should be
employed daily for the full three-month period of the
intervention. The investigator will instruct the partici-
pants on the use of the tool that evaluates food intake,
on how to enter the information and receive the recom-
mendations, and on how to use of the accelerometer
and read the generated information – with the recom-
mendation to reach a total of 10,000 daily steps. The
subjects will be required to daily enter food intake
(breakfast, lunch, afternoon snack, and dinner), selecting
the dishes and foods from the application menu. Regular
physical activity will be recorded with the accelerometer
of the device, together with due registry of those activ-
ities performed without the smartphone (swimming,
football, etc.). Lastly, the final daily summary will be
reviewed, with a balance of food intake and physical ac-
tivity, and the device will offer a recommended plan for
the next days, with a view to improving eating habits
and increasing physical activity. A new visit will be held
one week after supplying the device, in order to confirm
that it is being used correctly, and to clarify any possible
doubts. The smartphone will be returned after three
months, coinciding with the common review visit.
Blinding strategy
The investigator performing randomization and inter-
vention in the IG will be different from the investigator
conducting evaluation and the rest of interventions,
blinding will be maintained during the study, and the in-
vestigator performing data analysis also will be blinded.
Due to the nature of the study, the subjects cannot be
blinded to the intervention.
Project schedule
The project is planned as three yearly periods with sub-
sequent follow-up to evaluate the long-term effects of
the intervention. In a previous phase conducted in 2013,
the software for the smartphones was developed by the
company CGB, and a prior pilot evaluation was carried
out in Salamanca among users of both sexes with differ-
ent ages and cultural levels, to confirm the practical
feasibility of the tool and introduce any necessary changes.
In the present project, pilot evaluation will be made in
2014–2015, along with recruitment of all the subjects
and conduction of the first visits, while in 2015–2016
we will complete the follow-up visits (12 months) –
with conclusion of the operative phase of the project
on 31 December 2016.
The flow chart (Figure 3) shows the phases of the
clinical trial.
Figure 3 Flow - chart of EVIDENT II clinical trial.
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The results will be expressed as the mean ± standard de-
viation for quantitative variables or using the frequency
distribution for qualitative variables. Analysis of the
results will be made on an intent-to-treat (ITT) basis.
Statistical normality will be tested using the Kolmogorov-
Smirnov test. Use will be made of the chi-squared test to
analyze the association between independent qualitative
variables, along with the McNemar test for paired samples.
The Student t-test will be used for the comparison of
means between two groups, and the paired t-test will be ap-
plied to assess changes within one same group. Alterna-
tively, the corresponding nonparametric tests will be used,
as required. The relationship between quantitative variables
will be analyzed using Pearson’s correlation coefficient or
Spearman coefficient in the case of asymmetrically distrib-
uted variables. Multivariate linear regression analysis and
logistic regression analysis will be used to analyze the vari-
ables determining the changes in physical activity and eat-
ing habits, and in the arterial stiffness parameters (PWV,
AIx and CAVI). In order to analyze the effect of the inter-
vention, comparison will be made of the changes observed
in the control group (CG) versus the intervention group
(IG), with estimation of the Cohen d statistic, adjusting
for the variables that may influence the results. Logisticregression will analyze the odds ratio (OR) for achieving
the objectives of diet and exercise compliance. A multilevel
analysis will be performed to determine the effect of the dif-
ferent recruitment centers. Gender will be contemplated in
the analysis to assess differences between males and females
in terms of adherence to the smartphone application, and
in the middle- and long-term results. Likewise, an analysis
will be made according to the degree of motivation at base-
line assessment and adherence to use of the smartphone.
The effect of the intervention could be modified by age,
gender, cultural and socioeconomic level, body mass index
(BMI) and certain disease conditions, as well as by the
baseline lifestyles, which will be controlled in the ana-
lysis. The contrasting of hypotheses establishes α =
0.05. The IBM-SPSS version 20.0 statistical package
will be used throughout.
Quality control
In order to ensure data quality, the nursing professionals
in charge of data collection will receive specific training.
Regular external monitoring will then be performed in
the six health centers to verify adequate application of
methods, both in performing the different examinations
and collecting the information.
Methodological limitations
The study follows all the recommendations of the CON-
SORT, though in view of the nature of the intervention,
the participating subjects will not be blinded to the
intervention. Since we are dealing with lifestyle modifi-
cations, the analysis of the main results referred to the
Mediterranean diet is based on self-declared data, even
though use will be made of validated tools and the gen-
eral food questionnaire, which may serve as quality con-
trol. In any case, objective data will be available in the
case of physical exercise (accelerometer). Difficulties in
using the application may increase the number of drop-
outs in the intervention group.
Ethical and legal issues
The study has been approved by the clinical research
ethics committee (CEIC) of the healthcare area of Sala-
manca (“CEIC of Area de Salud de Salamanca”, 21 June
2013), as coordinating center, and by the ethics commit-
tees of the collaborating centers (“CEIC of Aragón
(CEICA), CEIC of IDIAP Jordi Gol, CEIC of Euskadi
(CEIC-E), CEIC of the Area integrada de salud de
Talavera de la Reina and CEIC of the Área de Salud
de Valladolid Oeste”). Subjects will be required to sign
the informed consent prior to inclusion in the study,
in accordance with the Declaration of Helsinki [67].
Subjects will be informed of the objectives of the project
and of the risks and benefits of the examinations made.
None of the examinations pose life-threatening risks for
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study includes the obtainment of biological samples; the
study subjects therefore will be informed in detail. The
confidentiality of the recruited subjects will be ensured
at all times in accordance with the provisions of current
legislation on personal data protection (15/1999 of 13
December, LOPD), and the conditions contemplated by
Act 14/2007 on biomedical research.
Discussion
The exponential development of smartphone applica-
tions in the field of healthcare has not been accompan-
ied by sufficient scientific evidence of the usefulness
of such applications in improving the health of the
population. As has already been called upon by different
organisms, and more specifically by the FDA, it seems
necessary to conduct experimental studies similar to
those used in pharmacological treatments, in order to
obtain sufficient scientific evidence of the possible use-
fulness of these tools.
The EVIDENT I study obtained evidence of the asso-
ciation between healthy lifestyles - particularly physical
activity and diet – and vascular structure and function.
Specifically, less physical activity or prolonged sedentar-
ism was associated to greater aging of the vascular sys-
tem [10,68].
The EVIDENT II study developed a smartphone appli-
cation that has already been tested in a prior pilot phase
designed to assess its reliability in the recording and ana-
lysis of diet and physical activity, as well as in relation to
the counseling needed to improve these parameters and
come closer to the international recommendations referred
to the compliance with the Mediterranean diet and physical
activity equivalent to at least 10,000 steps a day.
With this project we hope to demonstrate that regular
use of this application for at least three months is able
to modify certain habits, resulting in eating habits more
in line with the Mediterranean diet, which has already
demonstrated its benefits in terms of cardiovascular
morbidity-mortality [30]. Likewise, we hope to increase
the physical activity of the participants and to raise the
proportion of individuals considered to be active, as this
should imply multiple improvements in health – as has
already been demonstrated in different studies [1-3].
Although over the short term it will be difficult to
demonstrate the health benefits of the changes in diet
and physical activity, over the middle term we hope to
demonstrate that the use of this tool can not only im-
prove living habits but also afford benefits in terms of
vascular function - improving the parameters that assess
arterial stiffness, such as AIx, CAVI and PWV.
Therefore, the results of this study could lead to a
strategy based on the use of new technologies to delay
arterial aging, combining increased physical activity andeating habits adapted to the Mediterranean diet. This
strategy based on the incorporation of new technologies
that are widely disseminated among the population,
would result in healthy lifestyles and could constitute a
powerful tool against vascular aging.Additional file
Additional file 1: Informational brochure to support the common
intervention.
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